These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15715181)

  • 1. Mucociliary clearance in COPD can be increased by both a D2/beta2 and a standard beta2 agonists.
    Hasani A; Toms N; Agnew JE; Lloyd J; Dilworth JP
    Respir Med; 2005 Feb; 99(2):145-51. PubMed ID: 15715181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early clinical investigation of Viozan (sibenadet HCl), a novel D2 dopamine receptor, beta2-adrenoceptor agonist for the treatment of chronic obstructive pulmonary disease symptoms.
    Ind PW; Laitinen L; Laursen L; Wenzel S; Wouters E; Deamer L; Nystrom P
    Respir Med; 2003 Jan; 97 Suppl A():S9-21. PubMed ID: 12564607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the novel D2/beta2-agonist, Viozan (sibenadet HCl), in the treatment of symptoms of chronic obstructive pulmonary disease: results of a large-scale clinical investigation.
    Laursen LC; Lindqvist A; Hepburn T; Lloyd J; Perrett J; Sanders N; Rocchiccioli K
    Respir Med; 2003 Jan; 97 Suppl A():S23-33. PubMed ID: 12564608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptoms are an important outcome in chronic obstructive pulmonary disease clinical trials: results of a 3-month comparative study using the Breathlessness, Cough and Sputum Scale (BCSS).
    Celli B; Halpin D; Hepburn R; Byrne N; Keating ET; Goldman M
    Respir Med; 2003 Jan; 97 Suppl A():S35-43. PubMed ID: 12564609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term use of Viozan (sibenadet HCl) in patients with chronic obstructive pulmonary disease: results of a 1-year study.
    Hiller FC; Alderfer V; Goldman M
    Respir Med; 2003 Jan; 97 Suppl A():S45-52. PubMed ID: 12564610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual dopamine D2 receptor and beta2-adrenoceptor agonists for the treatment of chronic obstructive pulmonary disease: the pre-clinical rationale.
    Dougall IG; Young A; Ince F; Jackson DM
    Respir Med; 2003 Jan; 97 Suppl A():S3-7. PubMed ID: 12564606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of salmeterol xinafoate on lung mucociliary clearance in patients with asthma.
    Hasani A; Toms N; O'Connor J; Dilworth JP; Agnew JE
    Respir Med; 2003 Jun; 97(6):667-71. PubMed ID: 12814152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oral antibiotics on lung mucociliary clearance during exacerbation of chronic obstructive pulmonary disease.
    Hasani A; Pavia D; Rotondetto S; Clarke SW; Spiteri MA; Agnew JE
    Respir Med; 1998 Mar; 92(3):442-7. PubMed ID: 9692103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced effect of inhaled beta 2-adrenergic agonists on lung mucociliary clearance in patients with cystic fibrosis.
    Mortensen J; Hansen A; Falk M; Nielsen IK; Groth S
    Chest; 1993 Mar; 103(3):805-11. PubMed ID: 8095449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of single inhalation of a salbutamol, ipratropium bromide and beclomethasone on mucociliary clearance in patients with chronic obstructive airway disease.
    Guleria R; Singh TR; Sinha S; Padhy K; Gupta K; Pande JN
    Indian J Chest Dis Allied Sci; 2003; 45(4):241-6. PubMed ID: 12962458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by viozan of extravasation induced in rat trachea by capsaicin is mediated exclusively by beta 2-adrenoceptors.
    Fozard JR; Baur F; Wolber C; Collingwood SP
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec; 364(6):570-2. PubMed ID: 11770013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tiotropium on mucus hypersecretion and airway clearance in patients with COPD.
    Tagaya E; Yagi O; Sato A; Arimura K; Takeyama K; Kondo M; Tamaoki J
    Pulm Pharmacol Ther; 2016 Aug; 39():81-4. PubMed ID: 27350218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pulmonary and extra-pulmonary effects of high-dose formoterol in COPD: a comparison with salbutamol.
    Goldkorn A; Diotto P; Burgess C; Weatherall M; Holt S; Beasley R; Siebers R
    Respirology; 2004 Mar; 9(1):102-8. PubMed ID: 14982610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oral bronchodilators on lung mucociliary clearance during sleep in patients with asthma.
    Hasani A; Agnew JE; Pavia D; Vora H; Clarke SW
    Thorax; 1993 Mar; 48(3):287-9. PubMed ID: 8497831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of formoterol and tiotropium bromide on mucus clearance in patients with COPD.
    Meyer T; Reitmeir P; Brand P; Herpich C; Sommerer K; Schulze A; Scheuch G; Newman S
    Respir Med; 2011 Jun; 105(6):900-6. PubMed ID: 21397483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenoceptor responses of the airways: for better or worse?
    Broadley KJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):15-27. PubMed ID: 16469310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conclusion. Lessons from the novel D2 dopamine receptor, beta2-adrenoceptor agonist, Viozan: chronic obstructive pulmonary disease and drug development implications.
    Calverley P; Keating ET; Goldman M; Casty F
    Respir Med; 2003 Jan; 97 Suppl A():S71-4. PubMed ID: 12564613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Airway response of children with primary ciliary dyskinesia to exercise and beta2-agonist challenge.
    Phillips GE; Thomas S; Heather S; Bush A
    Eur Respir J; 1998 Jun; 11(6):1389-91. PubMed ID: 9657584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Laryngeal mucociliary clearance: influence of beta-2 agonists, beta antagonists, and alpha-agonists. An experimental study in rabbits].
    Armengot M; Garín L; Zapater E; Campos A; Basterra J
    Acta Otorrinolaringol Esp; 1996; 47(6):425-8. PubMed ID: 9044579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of nebulized levalbuterol in stable COPD.
    Datta D; Vitale A; Lahiri B; ZuWallack R
    Chest; 2003 Sep; 124(3):844-9. PubMed ID: 12970007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.